Abstracts of papers

Vermeulen NPE, Bessems JGM and Van de Straat R: Molecular aspects of paracetamol-induced hepatotoxicity and its mechanism-based prevention. Drug Metab. Rev.24, 367–407.Google Scholar

Koymans L and Vermeulen NPE: “Active site structure of and mechanism of oxidation by cytochromes P450: a review” Drug Metab. Rev. In press.Google Scholar

Vermeulen NPE, Donné-Op den Kelder and Commandeur JNM: Formation of and protection against toxic reactive intermediates. In: B. Testa, E. Kyburz, W Fuhrer and R. Giger (Eds),Proceedings XIIth international Symposium in Medical Chemistry, Basel, 13–18 September 1992, Verlag Helvetica Chimica Acta, Basel, and Verlag Chemie. Weinheim.Google Scholar

Van de Straat et al. (1986) Biochem. Pharmacol. 35:3693–3699PubMedGoogle Scholar

P.M. Caldirola, H. van der Goot and H. Timmerman. Eur. J. Med. Chem, in press.Google Scholar

Jandke, J. and Spiteller, G. (1987) J. Chromatogr. 421, 1–8.PubMedGoogle Scholar

Sanduja, R., Ansari, G. A. S., and Boor, P. J. (1989) J. Appl. Toxicol.9, 235–238.PubMedGoogle Scholar

J. Ch. Eriks et al., J. Med. Chem., 35 (1992) 3239.PubMedGoogle Scholar

H. Weinstein et al., Mol. Pharmacol., 12 (1976) 738.PubMedGoogle Scholar

D. M. Blow et al., Nature, 221 (1969) 337.PubMedGoogle Scholar

C. L. Cooper et al., J. Biol. Chem., 264 (1989) 6202.PubMedGoogle Scholar

M. J. A. Van Veldhuizen et al. Neurosci. Lett. 119 (1990) 233.PubMedGoogle Scholar

Vree TB et al. Biopharm Drug Dispos 1992;13:445–60PubMedGoogle Scholar

Vree TB et al. Pharm Weekbl [Sci] 1991;13:198–206Google Scholar

Vree TB et al. Pharm Weekbl [Sci] 1992;14:83–7.Google Scholar

Vree TB et al. J Chromatogr Biomed Appl 1992;578:239–49.Google Scholar